drugset / Trial / NCT05035069
Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to explore the efficacy and safety of ciprofol compared to propofol for non-intubated general anesthesia in patients undergoing transcatheter aortic valve replacement (TAVR).
Timeline
- Start
- 2021-09-03
- Primary completion
- 2022-02-03
- Completion
- 2022-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cipepofol | Small molecule | 0.2 mg/kg | — |
| Subject | Cipepofol | Small molecule | 0.6 mg/kg | — |
| Comparator | Propofol | Small molecule | 1 mg/kg | — |
| Comparator | Propofol | Small molecule | 3 mg/kg | — |
Indications
No indication recorded.